NasdaqGS:AGIOBiotechs
Agios Pharmaceuticals (AGIO) Posts $1.1 Billion One-Off Gain, Challenges Earnings Quality Narratives
Agios Pharmaceuticals (AGIO) posted a one-off gain of $1.1 billion, which drove its net profit margins into positive territory for the twelve months through September 30, 2025. Over the last five years, the company averaged 50.6% annual earnings growth, with revenue now forecast to climb 57.2% per year and EPS projected to rise 43.6% annually. Both of these rates are well in excess of the broader US market’s respective rates. Investors will be weighing the strong growth outlook and low...